141 related articles for article (PubMed ID: 25029120)
1. Isocitrate dehydrogenase-1 is mutated in inflammatory bowel disease-associated intestinal adenocarcinoma with low-grade tubuloglandular histology but not in sporadic intestinal adenocarcinoma.
Hartman DJ; Binion D; Regueiro M; Schraut W; Bahary N; Sun W; Nikiforova M; Pai RK
Am J Surg Pathol; 2014 Aug; 38(8):1147-56. PubMed ID: 25029120
[TBL] [Abstract][Full Text] [Related]
2. Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
Hartman DJ; Binion DG; Regueiro MD; Miller C; Herbst C; Pai RK
Inflamm Bowel Dis; 2018 Jul; 24(8):1780-1790. PubMed ID: 29788391
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas.
Loussouarn D; Le Loupp AG; Frenel JS; Leclair F; Von Deimling A; Aumont M; Martin S; Campone M; Denis MG
Int J Oncol; 2012 Jun; 40(6):2058-62. PubMed ID: 22447191
[TBL] [Abstract][Full Text] [Related]
4. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
[TBL] [Abstract][Full Text] [Related]
5. IDH1-mutated Crohn's disease-associated small bowel adenocarcinomas: Distinctive pathological features and association with MGMT methylation and serrated-type dysplasia.
Guerini C; Furlan D; Ferrario G; Grillo F; Libera L; Arpa G; Klersy C; Lenti MV; Riboni R; Solcia E; Fassan M; Mastracci L; Ardizzone S; Moens A; De Hertogh G; Ferrante M; Graham RP; Sessa F; Paulli M; Di Sabatino A; Vanoli A
Histopathology; 2024 Feb; 84(3):515-524. PubMed ID: 37988281
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease.
Malvi D; Vasuri F; Mattioli B; Gruppioni E; Fiorentino M; Gionchetti P; Grigioni WF; Poggioli G; D'Errico-Grigioni A
Pathology; 2014 Aug; 46(5):439-43. PubMed ID: 24977730
[TBL] [Abstract][Full Text] [Related]
7. IDH1 and IDH2 Mutations in Colorectal Cancers.
Huang J; Tseng LH; Parini V; Lokhandwala PM; Pallavajjala A; Rodriguez E; Xian R; Chen L; Gocke CD; Eshleman JR; Lin MT
Am J Clin Pathol; 2021 Oct; 156(5):777-786. PubMed ID: 33929516
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.
Wang XW; Boisselier B; Rossetto M; Marie Y; Idbaih A; Mokhtari K; Gousias K; Hoang-Xuan K; Delattre JY; Simon M; Labussière M; Sanson M
Cancer; 2013 Feb; 119(4):806-13. PubMed ID: 23184331
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and Molecular Characterisation of Crohn's Disease-associated Small Bowel Adenocarcinomas.
Liao X; Li G; McBride R; Houldsworth J; Harpaz N; Polydorides AD
J Crohns Colitis; 2020 Mar; 14(3):287-294. PubMed ID: 31388669
[TBL] [Abstract][Full Text] [Related]
10. High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas.
Diosdado B; Buffart TE; Watkins R; Carvalho B; Ylstra B; Tijssen M; Bolijn AS; Lewis F; Maude K; Verbeke C; Nagtegaal ID; Grabsch H; Mulder CJ; Quirke P; Howdle P; Meijer GA
Clin Cancer Res; 2010 Mar; 16(5):1391-401. PubMed ID: 20179237
[TBL] [Abstract][Full Text] [Related]
11. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.
Bleeker FE; Lamba S; Leenstra S; Troost D; Hulsebos T; Vandertop WP; Frattini M; Molinari F; Knowles M; Cerrato A; Rodolfo M; Scarpa A; Felicioni L; Buttitta F; Malatesta S; Marchetti A; Bardelli A
Hum Mutat; 2009 Jan; 30(1):7-11. PubMed ID: 19117336
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
13. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
Alpert L; Yassan L; Poon R; Kadri S; Niu N; Patil SA; Mujacic I; Montes D; Galbo F; Wurst MN; Zhen CJ; Cohen RD; Rubin DT; Pekow JR; Weber CR; Xiao SY; Hart J; Segal J; Setia N
Hum Pathol; 2019 Jul; 89():44-50. PubMed ID: 31054900
[TBL] [Abstract][Full Text] [Related]
14. IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution.
Rodriguez EF; De Marchi F; Lokhandwala PM; Belchis D; Xian R; Gocke CD; Eshleman JR; Illei P; Li MT
Cancer Med; 2020 Jun; 9(12):4386-4394. PubMed ID: 32333643
[TBL] [Abstract][Full Text] [Related]
15. IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri.
Narasimhaiah D; Miquel C; Verhamme E; Desclée P; Cosnard G; Godfraind C
Neuropathology; 2012 Feb; 32(1):30-7. PubMed ID: 21481010
[TBL] [Abstract][Full Text] [Related]
16. IDH mutations in glioma and acute myeloid leukemia.
Dang L; Jin S; Su SM
Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
[TBL] [Abstract][Full Text] [Related]
17. Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.
Zhang J; Jiang J; Luo Y; Li X; Lu Z; Liu Y; Huang J; Hou Y; Pang Y; Sun MYF; Wang TS; Evans DB; Pacak K; Zhuang Z; Gao X
Endocrine; 2018 Aug; 61(2):216-223. PubMed ID: 29846902
[TBL] [Abstract][Full Text] [Related]
18. Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease.
Levi GS; Harpaz N
Am J Surg Pathol; 2006 Aug; 30(8):1022-9. PubMed ID: 16861975
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations.
Toth LN; de Abreu FB; Tafe LJ
Hum Pathol; 2018 Aug; 78():138-143. PubMed ID: 29723602
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between clinical characteristics and myelodysplastic syndrome patients with isocitrate dehydrogenase gene mutations].
Tong HY; Hu C; Yu MX; Ma QL; Chen FF; Ye L; Wei JY; Xu GX; Mao LP; Li Y; Jin J
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3180-4. PubMed ID: 24405536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
